Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05892302 · ClinicalTrials.gov registry record · NA
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
A NA study of Asthma in Children, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05892302: Recruiting NA study of Asthma in Children, sponsored by University of Texas at Austin.
NCT05892302 is a NA study of Asthma in Children that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 50 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05892302, a NA study of Asthma in Children, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.
Primary Outcome
Engagement is a composite outcome which is defined as engagement with at least 2 of the 3 toolkits. It will be expressed as the percentage of participants with engagement. Engagement with each of the toolkits is defined as follows: (i) Asthma Specialist: at least one documented appointment with an asthma specialist; (ii) Asthma Management: Controller medication prescription fills covering at least 3 months of dosing; (iii) Home environment Toolkit: New deployment of at least some of the availab
Conditions Studied
Interventions
- BEHAVIORAL Access to Asma Guardian website/app
- BEHAVIORAL Delayed Access to Asma Guardian website/app
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What NCT05892302 shows while recruiting
NCT05892302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Access to Asma Guardian website/app is the first listed.
NCT05892302 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05892302 about?
NCT05892302 is a clinical study titled "A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)". This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.
What is the current status of trial NCT05892302?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-03-22. Estimated completion is 2025-05-01.
What conditions does trial NCT05892302 study?
This clinical trial studies the following conditions: Asthma in Children.
What interventions are being tested in trial NCT05892302?
The interventions under investigation include: Access to Asma Guardian website/app (BEHAVIORAL), Delayed Access to Asma Guardian website/app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05892302?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05892302 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05892302's enrollment target sits among peer trials
50 31st of 44 higher than 13 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
-
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
RECRUITING · NA
-
Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI